Daniel C Schmiesing

Title: The Innovations of Daniel C. Schmiesing

Introduction

Daniel C. Schmiesing is an accomplished inventor based in Bothell, WA (US). He has made significant contributions to the field of medical technology, particularly in the area of cardiac monitoring. His innovative approach has led to the development of a unique patent that enhances the way cardiac blood flow information is displayed.

Latest Patents

Daniel holds a patent for a technique titled "Continuous display of cardiac blood flow information." This invention focuses on continuously determining and displaying the peak velocities of spectral Doppler information. The method involves establishing a Doppler noise threshold level based on the operating characteristics of the ultrasound system and probe. By comparing received spectral Doppler data to this threshold, valid peak velocity values can be identified. The invention also addresses artifacts such as valve clicks by examining spectral lines before display. Peak velocity values are interpolated and displayed in place of these artifacts. Furthermore, the invention allows for the selection of individual heart cycles based on R-wave intervals from an ECG trace, automatically highlighting the relevant spectral Doppler display for the user.

Career Highlights

Daniel is currently employed at Advanced Technology Laboratories, Inc., where he continues to innovate in the field of medical technology. His work has been instrumental in advancing cardiac monitoring techniques, making significant impacts on patient care.

Collaborations

Throughout his career, Daniel has collaborated with notable colleagues, including Helen Frances Routh and Bruce Adrian Kincy. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Daniel C. Schmiesing's contributions to medical technology, particularly through his patent on cardiac blood flow information display, exemplify the impact of innovation in healthcare. His work continues to influence the field and improve patient outcomes.